2023 Neuroimaging Reading List

Reading List

Please click below to access the 2023 Neuroimaging reading list.

2023 Neuroimaging Reading List »

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

Upon completion of this UCNS C-cert activity, participants will be able to:
  • Understand how newer imaging of the vessel wall and vascular malformations can help with diagnosis
  • Evaluate findings related to tau and amyloid deposition in neuroimaging
  • Understand imaging in MS and epilepsy in regard to timing and sequences
  • Identify how imaging finding results in abusive head trauma in children can relate to prognosis in admission


The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy

2023 C-cert Activity Planner Disclosures
All relevant financial relationships have been mitigated.

Neuroimaging Certification Examination Committee Contributors

Jerome J. Graber, MD, MPH, Chair, Alvord Brain Tumor Center
Disclosures: Received personal compensation from the American Society of Neuroimaging for serving as a Social Media Editor for their Journal of Neuroimaging, published by Wiley. 

Jennifer Williams McVige, MD, Vice Chair, Dent Neurologic Institute
Disclosures: Received consulting fees from Abbvie, Avanir, Theranica, Biohaven, and Teva; served on scientific advisory boards for Abbvie, Biohaven, and Teva; speakers bureau for Abbvie, Avanir, Lilly, Amgen, Biohaven, Teva, Neurelis, Impel Pharmaceuticals; Cephalalgia, Headache (never received the compensation though); DENT Neurologic Institute Board of Directors (no compensation) American Society for Neuroimaging Board of Directors (no compensation); expert witness periodically for patient's No Fault cases; research support from Dent Family Foundation (non profit), Teva, Lilly, Amgen, Biohaven, Abbvie; serve as an ABPN advisor for neuroimaging exam items to assess quality – does not regularly write questions.

Jon Y. Choi, MD, PhD, Walter Reed National Military Medical Center
Disclosures: Nothing to disclose.

Carmel Armon, MD, MHS, Shamir (Assaf Harofeh) Medical Center, Israel 
Disclosures: Compensated as Associate Editor, Journal of the Neurological Sciences; Chair, Appeals Panel, Neurology Certifying Examination, Parts A&B, Scientific Council, Israeli Medical Association.

Alireza Faridar, MD, Houston Methodist Hospital
Disclosures: Nothing to disclose.

Dimitrios Giannakidis, MD, Sutter West Bay Medical Group
Disclosures: Nothing to disclose.

Mohammad Obadah Nakawah, MD, Houston Methodist Neurological Institute 
Disclosures: Nothing to disclose.

Gustavo J. Rodriguez, MD, Texas Tech Physicians of El Paso
Disclosures: Nothing to disclose.

Catherine A. Weymann-McKinney, MD, Lake Norman Neurology Hickory – Piedmont Healthcare
Disclosures: Nothing to disclose.

Gregory Kapinos, MD, MS, HEC-C, NYC Health + Hospitals/Elmhurst
Disclosures: Nothing to disclose.

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326